These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 15448664

  • 1. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    Thomas X, Boiron JM, Huguet F, Reman O, Sutton L, Turlure P, Garban F, Gardin C, Espinouse D, Boulat O, Lhéritier V, Fiere D, Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group).
    Hematol J; 2004; 5(5):384-94. PubMed ID: 15448664
    [Abstract] [Full Text] [Related]

  • 2. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Heath JA, Steinherz PG, Altman A, Sather H, Jhanwar S, Halpern S, Pieters R, Shah N, Steinherz L, Tannous R, Terry W, Trigg ME, Children's Cancer Group.
    J Clin Oncol; 2003 Apr 15; 21(8):1612-7. PubMed ID: 12697887
    [Abstract] [Full Text] [Related]

  • 3. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
    Alvarado Ibarra ML, Borbolla Escoboza JR, López-Hernández MA, González-Avante CM, FloresChapa JD, Trueba Christy E, Anaya Cuellar I.
    Rev Invest Clin; 1999 Apr 15; 51(2):77-80. PubMed ID: 10410585
    [Abstract] [Full Text] [Related]

  • 4. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
    Michel G, Landman-Parker J, Auclerc MF, Mathey C, Leblanc T, Legall E, Bordigoni P, Lamagnere JP, Demeocq F, Perel Y, Auvrignon A, Berthou C, Bauduer F, Pautard B, Schneider P, Schaison G, Leverger G, Baruchel A.
    J Clin Oncol; 2000 Apr 15; 18(7):1517-24. PubMed ID: 10735900
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group.
    Ohno R, Tomonaga M, Ohshima T, Masaoka T, Asou N, Oh H, Nishikawa K, Kanamaru A, Murakami H, Furusawa S.
    Int J Hematol; 1993 Aug 15; 58(1-2):73-81. PubMed ID: 7693029
    [Abstract] [Full Text] [Related]

  • 7. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI, Rivera F, Díaz-Puente MT, Lianes P, Colomer R, López-Brea M, López E, Paz-Ares L, Hitt R, García-Ribas I.
    J Natl Cancer Inst; 1995 Jun 07; 87(11):803-8. PubMed ID: 7540696
    [Abstract] [Full Text] [Related]

  • 8. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
    Pui CH, Boyett JM, Hughes WT, Rivera GK, Hancock ML, Sandlund JT, Synold T, Relling MV, Ribeiro RC, Crist WM, Evans WE.
    N Engl J Med; 1997 Jun 19; 336(25):1781-7. PubMed ID: 9187068
    [Abstract] [Full Text] [Related]

  • 9. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
    Welte K, Reiter A, Mempel K, Pfetsch M, Schwab G, Schrappe M, Riehm H.
    Blood; 1996 Apr 15; 87(8):3143-50. PubMed ID: 8605328
    [Abstract] [Full Text] [Related]

  • 10. Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial.
    Ottmann OG, Hoelzer D, Gracien E, Ganser A, Kelly K, Reutzel R, Lipp T, Busch FW, Schwonzen M, Heil G.
    Blood; 1995 Jul 15; 86(2):444-50. PubMed ID: 7541660
    [Abstract] [Full Text] [Related]

  • 11. Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children.
    Saarinen-Pihkala UM, Lanning M, Perkkiö M, Mäkipernaa A, Salmi TT, Hovi L, Vettenranta K.
    Med Pediatr Oncol; 2000 May 15; 34(5):319-27. PubMed ID: 10797353
    [Abstract] [Full Text] [Related]

  • 12. Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Zittoun R, Suciu S, Mandelli F, de Witte T, Thaler J, Stryckmans P, Hayat M, Peetermans M, Cadiou M, Solbu G, Petti MC, Willemze R.
    J Clin Oncol; 1996 Jul 15; 14(7):2150-9. PubMed ID: 8683249
    [Abstract] [Full Text] [Related]

  • 13. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.
    Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA.
    Blood; 1998 Sep 01; 92(5):1556-64. PubMed ID: 9716583
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.
    Thomas X, Raffoux E, Botton Sd, Pautas C, Arnaud P, de Revel T, Reman O, Terré C, Corront B, Gardin C, Le QH, Quesnel B, Cordonnier C, Bourhis JH, Elhamri M, Fenaux P, Preudhomme C, Michallet M, Castaigne S, Dombret H.
    Leukemia; 2007 Mar 01; 21(3):453-61. PubMed ID: 17252021
    [Abstract] [Full Text] [Related]

  • 19. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
    Bunn PA, Crowley J, Kelly K, Hazuka MB, Beasley K, Upchurch C, Livingston R, Weiss GR, Hicks WJ, Gandara DR.
    J Clin Oncol; 1995 Jul 01; 13(7):1632-41. PubMed ID: 7602352
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR.
    J Clin Oncol; 2004 Aug 15; 22(16):3350-6. PubMed ID: 15310780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.